Leadership & Pay ·
On August 25, 2026, Dr. Andrew Keller notified Sunshine Biopharma Inc. that he will not seek reelection to the Board…
SBFMWSunshine Biopharma Inc.
On August 25, 2026, Dr. Andrew Keller notified Sunshine Biopharma Inc. that he will not seek reelection to the Board of Directors upon the expiration of his current term at the next annual shareholder meeting. This departure is a routine change in board composition and does not involve key executive officers or contested governance matters. The company operates in the biotechnology industry, focusing on drug discovery and development.